广东
分享至
智通财经APP讯，奥泰生物(688606.SH)披露2024年第三季度报告，公司前三季度实现营收6.18亿元，同比增长10.37%;归母净利润1.98亿元，同比增长94.48%;扣非净利润1.54亿元，同比增长59.78%;基本每股收益2.49元。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
